+ All Categories
Home > Documents > TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Date post: 24-Dec-2015
Category:
Upload: angela-bishop
View: 224 times
Download: 3 times
Share this document with a friend
Popular Tags:
32
TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT
Transcript
Page 1: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

TRANSCRANIAL MAGNETIC STIMULATION

Faten Alzaben PGY5 RESIDENT

Page 2: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

What is it?

TMS is a non-invasive method of brain stimulation in which magnetic fields are used to induce electric currents in the cerebral cortex, thereby depolarizing neurons.

Page 3: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Early Attempts!

Page 4: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Modern Application

Page 5: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Even More Modern

Page 6: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

History

the idea of using TMS goes back to the early 1900s.

1985 tony barker and colleagues .

1984 David Cohen, 1988 Shoogo Ueno : the idea and realization of the figure-of-

eight coil .

Page 7: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Mechanism of action of TMS

Electrical energy is converted to magnetic fields ,which are then converted back into electrical currents in the brain.

TMS is sometimes called”electrodeless electrical stimulation”

Page 8: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Applications of TMS

A research tool to study aspects of the human brain physiology

Therapeutic application: Neurological disorders Psychiatric disorders

Page 9: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

TMS as a research tool

A research tool to study aspects of the human brain physiology including motor function,vision,language and the pathophysiology of brain disorders

TMS can excite or inhibit the brain allowing functional mapping of cortical regions and creation of transient functional lesions.

Page 10: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Examples:

rTMS over the occipital lobe impaired detection of visual stimuli

rTMS delivered to discrete areas in the language-dominant hemisphere can disrupt speech.

Page 11: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Therapeutic Application in Neurological Disorders

Page 12: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Movement disorders:

Therapeutic applications of TMS in movement disorders are preliminary.

Fast rTMS of the motor cortex has been reported to improve performance on several motor measures in Parkinson disease.

a recent meta-analysis included 12 studies and concludes that the overall literature does show a positive effect of r TMS on Parkinson motor function.

Slow rTMS has been reported to improve dystonia. George, linsbey ,and

sackiem Fregni et al. 2005

Page 13: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Neuro-rehabilitation

TMS to evaluate the functional properties of the motor cortex after lesions like stroke is of special interest in the field of neurorehabilitation.

Brain stimulation have been proposed to enhance motor function when combined with conventional neurorehabilitative interventions after stroke

Page 14: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Chronic Pain

(rTMS) of the cortex induces analgesic effects in focal chronic pain syndromes.

Page 15: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Therapeutic Application in Psychiatric Disorders

Page 16: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Mood Disorders

Several studies demonstrated that repetitive transcranial magnetic stimulation (rTMS) is an

efficacious treatment for treatment-resistant major depression.

its efficacy has often been shown to be modest, compared with sham stimulation.

 

Page 17: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Mechanisms of rTMS-Induced Antidepressant Response

evidence suggests that MDD is most commonly associated with hypoexcitability over the left prefrontal cortex and hyperexcitability over the right prefrontal cortex

Page 18: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Evidence in support left prefrontal hypoexcitablity in depression: Brain injury:

patients with left-sided strokes (hypoexcitability) experience depression

Patients with right-sided strokes experience manic symptoms

Imaging studies demonstrated that MDD may involve lower activity in the left DPLFC and higher activity in the right DPLFC.

Page 19: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

rTMS treatment in MDD has often been shown to be associated with a normalization of hypoexcitability over the left prefrontal cortex and normalization of hyperexcitability over the right hemisphere.

 

Page 20: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Studies have demonstrated that when 10 Hz rTMS is applied to the right DLPFC , dysphoric symptoms occur.

Page 21: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Review of Studies of rTMS in Depression Studies in the review were summarized into 5 broad

categories: 1- first-generation studies that have evaluated the efficacy of

10 rTMS sessions (that is, 2 weeks) for TRD.  2-second-generation studies that have evaluated the efficacy

of rTMS for more than 10 rTMS sessions.

3-third-generation studies that evaluate the efficacy of rTMS using several novel treatment approaches (for example, bilateral rTMS).

  4- metaanalytic studies of rTMS for TRD.  5-future studies proposing novel methods to optimize the

efficacy of rTMS for TRD.The Canadian Journal of Psychiatry, Vol 53, No 9, September 2008

Page 22: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

First-Generation Studies

rTMS studies applied at high frequencies (10 to 20 Hz) over the left prefrontal cortex have demonstrated efficacy in the treatment of depression.

Other studies also demonstrated right low-frequency rTMS to be useful in depression.

Other first-generation studies were equivocal or showed lack of efficacy.

Other studies have also reported negligible results.

Page 23: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Explanations :1- most patients included in these studies

were treatment resistant.

2- stimulation parameters including frequency, intensity, and duration vary from study to study.

3- concomitant use of medications .

4- no consistent method for precisely localizing the prefrontal cortex.

Page 24: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Second-Generation Studies 20 or more treatments.

The results demonstrate that both HFL- and LFR-rTMS have substantial therapeutic efficacy.

Page 25: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Third-Generation Studies

bilateral rTMS. The studies showed no difference

between the groups. Limitations of these studies:

First, bilateral rTMS was not compared with unilateraland sham rTMS in a sufficiently large sample of subject.

none of the studies were conducted for longer than 10 days .

none used more than 300 LFR-rTMS pulses.

Page 26: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Metaanalyses of rTMS in MDD There have been at least 8 meta -

analyses evaluating the anti-depressant effects of left DLPFC rTMS. All but one have shown greater antidepressant effects at 2 weeks of HFL-rTMS, compared with sham.

Page 27: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Limitations of Current rTMS Trials in MDDFactors underlie the relative modest

therapeutic efficacy of rTMS studies conducted in MDD:

1- most of these studies involved left-sided treatment alone to the DLPFC.

2- suboptimal methods were used to target the DLPFC .

3-treatment durations were typically short (that is, 2 to 4 weeks).

4- stimulation intensity might have been insufficient by

not taking into consideration coil-to-cortex distance

Page 28: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Anxiety Disorders

obsessive-compulsive disorder posttraumatic stress disorder panic disorder

Page 29: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Schizophrenia

reduced auditory hallucinations reduced anxiety

Page 30: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Difference Between TMS and ECT  TMS:

does not require general anaesthesia easy to administer in alert and wake

subjects under medical supervision no cognitive deficits reported at this point. Does not involve induction of seizures

Page 31: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Adverse Effects of rTMS

Risk of inducing seizures (in patients with a hx or family hx of seizures).current safety protocols adjust the amount of stimulation in relation to the motor threshold of the individual.

Muscle tension headache . Short term changes in hearing threshold

related to the noise generated. Cognitive changes only during stimulation

Page 32: TRANSCRANIAL MAGNETIC STIMULATION Faten Alzaben PGY5 RESIDENT.

Thank You !


Recommended